Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients

Clinical Pharmacology and Therapeutics

Volumn 75, Issue 4, 2004, Pages 352-361

  Masuda, Satohiro ^b   Uemoto, Shinji ^b   Goto, Maki ^b   Fujimoto, Yasuhiro ^b   Tanaka, Koichi ^b   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTOCHROME P450 3A4; GANCICLOVIR; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; METHYLPREDNISOLONE; MICONAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISOLONE; STEROID; TACROLIMUS;

ARTICLE; CASE REPORT; CORRELATION ANALYSIS; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HUMAN; INTESTINE ABSORPTION; INTESTINE BIOPSY; INTESTINE CELL; INTESTINE GRAFT; MALE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL INFECTION;

ABNORMALITIES; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; ORGAN TRANSPLANTATION; P-GLYCOPROTEIN; RISK ASSESSMENT; RNA, MESSENGER; SAMPLING STUDIES; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 1842737790     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2003.11.374     Document Type: Article

References (20)

1. Uemoto S., Fujimoto Y., Inomata Y., Egawa H., Asonuma K., Pollard S., et al. Living-related small bowel transplantation the first case in Japan. Pediatr Transplant. 2:1998;40-44.
2. Farmer D.G., McDiarmid S.V., Yersiz H., Cortina G., Amersi F., Vargas J., et al. Outcome after intestinal transplantation results from one center's 9-year experience. Arch Surg. 136:2001;1027-1031.
3. Kumar N., Grant D. Gastrointestinal transplantation an update. Liver Transpl. 6:2000;515-519.
4. Venkataramanan R., Swaminathan A., Prasad T., Jain A., Zuckerman S., Warty V., et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 29:1995;404-430.
5. Hebert M.F. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev. 27:1997;201-214.
6. Kaplan B., Lown K., Craig R., Abecassis M., Kaufman D., Leventhal J., et al. Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient possible relationship to intestinal P-glycoprotein activity. Transplantation. 67:1999;333-335.
7. Shimomura M., Masuda S., Saito H., Sakamoto S., Uemoto S., Tanaka K., et al. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J Surg Res. 103:2002;215-222.
8. Masuda S., Uemoto S., Hashida T., Inomata Y., Tanaka K., Inui K. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin Pharmacol Ther. 68:2000;98-103.
9. Hashida T., Masuda S., Uemoto S., Saito H., Tanaka K., Inui K. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther. 69:2001;308-316.
10. Fujimoto Y., Uemoto S., Inomata Y., Egawa H., Fujita S., Kawanami T., et al. Small bowel transplantation using grafts from living-related donors. Two case reports. Transpl Int. 13:(Suppl 1):2000;S179-184.
11. Koch I., Weil R., Wolbold R., Brockmoller J., Hustert E., Burk O., et al. Interindividual variability and tissue-specificity in the expression of cytochrome p450 3A mRNA. Drug Metab Dispos. 30:2002;1108-1114.
12. Motohashi H., Sakurai Y., Saito H., Masuda S., Urakami Y., Goto M., et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol. 13:2002;866-874.
13. Goto M., Masuda S., Saito H., Inui K. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2. Biochem Pharmacol. 66:2003;163-170.
14. Vos T.A., Ros J.E., Havinga R., Moshage H., Kuipers F., Jansen P.L., et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology. 29:1999;1833-1839.
15. Gordon J.I. Intestinal epithelial differentiation new insights from chimeric and transgenic mice. J Cell Biol. 108:1989;1187-1194.
16. Trezise A.E., Romano P.R., Gill D.R., Hyde S.C., Sepulveda F.V., Buchwald M., et al. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 11:1992;4291-4303.
17. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., Vilarem M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta. 1619:2003;243-253.
18. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., Kliewer S.A. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 62:2002;638-646.
19. Zhao J.Y., Ikeguchi M., Eckersberg T., Kuo M.T. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology. 133:1993;521-528.
20. Fukudo M., Yano I., Fukatsu S., Saito H., Uemoto S., Kiuchi T., et al. Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation. Clin Pharmacokinet. 42:2003;1161-1178.